Concepedia
Statistics
Publications
3
Citations
145
H-Index
Active since
2014
Affiliations
Texas Tech University Health Sciences Center(Current)
The University of Texas Southwestern Medical Center
Texas Tech University
J. Bolluyt is an author at Texas Tech University Health Sciences Center specializing in medicine, oncology, and molecular oncology.
Publications per year
2014–2018
Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis
David E. Gerber, Muhammad Shaalan Beg, Farjana Fattah et al. · British Journal of Cancer · 2018 · 97 citations · Full text
Medicine, Oncology, Pharmacology +12
Using a novel NQO1 bioactivatable drug, beta‐lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer
Muhammad Shaalan Beg, Xiumei Huang, Molly A. Silvers et al. · Journal of Surgical Oncology · 2017 · 37 citations
Medicine, Biochemistry, Oncology +17
253 Phase 1 correlative study of ARQ761, a β-lapachone analogue that promotes NQ01-mediated programmed cancer cell necrosis
David E. Gerber, Yull Arriaga, Muhammad Shaalan Beg et al. · European Journal of Cancer · 2014 · 11 citations
Medicine, Oncology, Pharmacology +9
1–3 of 3